Max Robotics — Global Service Robot Directory + US Certification

About

Peter Iversen is a leading urologic surgeon and researcher whose work has significantly advanced the understanding and outcomes of robot-assisted radical prostatectomy (RARP). His research centers on optimizing surgical techniques for prostate cancer, with a particular focus on improving postoperative quality of life. Iversen’s major contributions include pioneering the use of the survival, continence, and potency (SCP) system to systematically report functional and oncological outcomes, providing a clearer benchmark for recovery after RARP. His influential study on early biochemical recurrence, urinary continence, and potency (25 citations) has helped refine patient expectations and surgical counseling. Additionally, his comparative analysis of anastomotic complications between robot-assisted and open radical prostatectomy (19 citations) has informed best practices for reducing postoperative strictures and leakages. Iversen also demonstrated clinical acumen in a notable case report on 68Ga-PSMA uptake in a pancreatic neuroendocrine tumor (8 citations), highlighting the importance of differential diagnosis in prostate cancer surveillance. His work has been instrumental in establishing RARP as a safe, effective procedure, with his early departmental series (2 citations) confirming low complication rates. Through his rigorous outcomes research, Iversen has helped shape modern prostate cancer surgery, balancing oncologic control with functional preservation.